Recent studies suggest that increased activity of the coagulation syst
em, measured with sensitive assays for activation markers, may be impo
rtant in the pathogenesis of vascular occlusion in sickle cell disease
(SCD). Since most of these studies were carried out in adult patients
and SCD is an inherited disorder with severe morbidity even in childh
ood, we decided to determine the activity of the coagulation system in
children with SCD. In a prospective study markers of thrombin generat
ion as well as coagulation inhibitors were investigated in 16 homozygo
us SCD patients and 16 age-matched control children. Significantly inc
reased plasma concentrations of the prothrombin fragment F-1+2 and of
thrombin-antithrombin III (TAT) complexes were found in SCD patients.
The levels of protein C activity and total and free protein S were sig
nificantly reduced in SCD patients as compared with control values. Pl
asma ATIII levels were not different in the two groups. We conclude th
at, in children with SCD, evidence of enhanced thrombin generation is
present, which may in part be due to reduced levels of the inhibitors
proteins C and S. The clinical relevance of this coagulation imbalance
has to be demonstrated.